VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 176 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,104,732 | +162.1% | 255,725 | +348.3% | 0.00% | +50.0% |
| Q4 2022 | $421,540 | -33.1% | 57,042 | -1.4% | 0.00% | -60.0% |
| Q2 2022 | $630,000 | -36.7% | 57,842 | -34.3% | 0.01% | -37.5% |
| Q1 2022 | $996,000 | -21.4% | 88,076 | +9.0% | 0.01% | -20.0% |
| Q4 2021 | $1,267,000 | +29.8% | 80,779 | +24.3% | 0.01% | -33.3% |
| Q1 2021 | $976,000 | +356.1% | 64,980 | +298.1% | 0.02% | +400.0% |
| Q4 2020 | $214,000 | +41.7% | 16,324 | +4.3% | 0.00% | +50.0% |
| Q3 2020 | $151,000 | -23.7% | 15,654 | +30.1% | 0.00% | -66.7% |
| Q4 2019 | $198,000 | – | 12,036 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |